ArticleMolecular biology reports2026
Vitamin D delivered through carbon quantum dots modifies cytokine expression and migration in MCF-7 breast cancer cells.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundVitamin D is a crucial regulator of immune responses and has recognized anti-proliferative effects in cancer. However, its clinical use is limited by poor solubility and bioavailability. Nanocarrier systems, such as carbon quantum dots (CQDs), may improve vitamin D delivery and activity.
methodsMCF-7 breast cancer cells were treated with free vitamin D or vitamin D-loaded CQDs (CQD-VitD). Cell viability was measured using the WST-8 assay; migration was assessed with a wound-healing assay; and gene expression of IL-6, IL-10, NF-κB, TNF-α, and VDR was analyzed through qRT-PCR.
resultsCQD-VitD significantly increased cell viability compared to both control and free vitamin D (p < 0.01). Wound-healing assays demonstrated that CQD-VitD markedly inhibited cell migration, while free vitamin D caused moderate wound closure. Gene expression analysis showed that free vitamin D slightly decreased IL-6 and significantly suppressed IL-10 (p < 0.05). Conversely, CQD-VitD strongly upregulated IL-10 (p < 0.001) and NF-κB (p < 0.05), with TNF-α and VDR expression remaining unchanged.
conclusionCQD-based delivery of vitamin D enhances its cellular activity and selectively affects immune-related genes in breast cancer cells. Although CQD-VitD reduced migration and increased cell viability, its upregulation of IL-10 and NF-κB suggests a complex role in tumor-immune interactions. These findings highlight both the potential and the challenges of nanocarrier-mediated vitamin D delivery in breast cancer therapy. To our knowledge, this is the first study to investigate the effects of vitamin D-loaded carbon quantum dots on immune-related gene expression in breast cancer cells.
Indexed as
Identifiers
42525170What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.